Interferon-regulating activity of the celagrip antiviral drug and its influence on formation of reactive oxygen species and expression of innate immunity genes in the follicular lymphoma patients

Autor: A. N. Narovlyansky, V. V. Poloskov, A. M. Ivanova, S. K. Kravchenko, F. E. Babayeva, K. A. Sychevskaya, M. V. Mezentseva, I. A. Suetina, L. I. Russu, A. V. Izmest’eva, T. P. Ospelnikova, A. A. Sarymsakov, F. I. Ershov
Jazyk: English<br />Russian
Rok vydání: 2020
Předmět:
Zdroj: Вопросы вирусологии, Vol 65, Iss 5, Pp 284-293 (2020)
Druh dokumentu: article
ISSN: 0507-4088
2411-2097
DOI: 10.36233/0507-4088-2020-65-5-5
Popis: Introduction. Medicines from the group of interferon inducers (IFNs) “swith on” the synthesis of type 1 interferons (IFN-I) and induce the expression of IFN-stimulated genes (ISGs) that regulate innate immunity reactions and protect the host from infectious agents and the tumour pathology. The purpose of the study was to determine the role of the drug celagrip (CA) in the activation of innate immunity genes and the effect on the production of reactive oxygen species (ROS) in patients with follicular lymphoma (FL). Objectives: to study the intensity of ROS production and the level of expression of the IFN-α2, IFN-λ1, ISG15, BCL2, P53(TP53) and USP18 genes in response to the treatment of blood cells of patients with FL with the preparation of CA. Material and methods. The study involved primary cancer patients diagnosed with follicular lymphoma (FL) and healthy volunteers. A kinetic analysis of the dynamics of production of reactive oxygen species (ROS) was performed in whose blood cells, and the expression of the group of genes was determined by real-time PCR in response to CA processing. Results and discussion. ROS production by blood cells of patients with FL and volunteers in the presence of CA significantly decreased (P 0.05). The level of gene expression of ISG15, P53(TR53) and USP 18 in the group of patients with FL was significantly higher than that in the group of volunteers. When treating blood cells with CA, it becomes possible to divide patients with FL into groups with a positive and negative response in accordance with the level of expression of the USP18 gene. We divided FL patients into groups with a positive and negative response in accordance with the level of USP18 gene expression after treatment of blood cells with CA. Conclusions. The CA drug reduces the production of ROS and simultaneously stimulates the activity of the innate immunity genes ISG15, P53(TP53) and USP18 in the blood cells of patients with FL.
Databáze: Directory of Open Access Journals
Externí odkaz: